GI & Endoscopy

Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics

Researchers from the Shanghai Jiao Tong University in China have found that metformin treatment lowers the risk of colorectal cancer in patients with type two diabetes, according to a news release.

By: Staff

Monday, October 17th, 2011

The researchers analyzed five studies from Jan. 1966-Mar. 2011, which consisted of 108,161 participants, to look for links between metformin and colon cancer incidence. The analysis revealed a 37 percent decrease in risk.

Next Up in GI & Endoscopy

GIs sound the alarm on CMS payment changes

Gastroenterologists are raising concerns about the CMS’ finalized payment policies, according to a joint statement from the American College of…

By: Patsy Newitt
11 hours ago
The new frontiers in GI care

As gastroenterology evolves, leaders are reimagining how to deliver comprehensive, patient-centered care. Dinesh Madhok, MD, CEO of Jacksonville, Fla.-based Borland…

By: Patsy Newitt
14 hours ago
FDA approves 1st IBS-C drug for children

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation,…

By: Patsy Newitt
14 hours ago

Comments are closed.

Rewriting the Labor Playbook: Workforce Intelligence and Enablement as a catalyst for sustainable margin improvement, smarter physician compensation, and enhanced staff well-being

Next Up in GI & Endoscopy

GIs sound the alarm on CMS payment changes

The new frontiers in GI care

FDA approves 1st IBS-C drug for children

Join the 40,000+ ASC leaders who start their day with Becker's